PREVALENCE OF OBSTRUCTIVE SLEEP APNEA IN CASES OF METABOLIC SYNDROME: A CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i6.51540Keywords:
Obstructive sleep apnea, Metabolic syndrome, Snoring, Daytime somnolence.Abstract
Objectives: The study aimed to find out the prevalence of obstructive sleep apnea (OSA) in individuals with metabolic syndrome (MS).
Methods: This was a cross-sectional study conducted in the department of respiratory medicine of a tertiary care medical institute. Eighty patients infected with MS diagnosed on the basis of national cholesterol education program adult treatment panel III criteria were included in this study on the basis of predefined inclusion and exclusion criteria. Demographic details such as age, gender, and socioeconomic status of all the patients were noted. A thorough general and clinical examination was conducted, including the assessment of vital signs. Polysomnography was done in all cases and the diagnosis of OSA was based on polysomnography results. SSPS 21.0 was used for statistical analysis and p<0.05 was taken as statistically significant.
Results: Out of 80 patients, there were 58 (72.50%) males and 22 (27.50%) females with a M: F ratio of 1: 0.37. The overall mean age of the studied cases was found to be 44.60±12.92. Mild (apnea-hypopnea index [AHI] 5–14), moderate (AHI=15–30), and severe OSA (AHI >30) was seen in 33 (41.25%), 17 (21.25%) and 9 (11.25%) patients, respectively. Overall prevalence of OSA in cases of MS was found to be 73.75% as the severity of OSA increased there was decreased in mean sleep time and the difference was found to be statistically significant (p<0.05). The most common presenting complaint was loud snoring, observed in 55 patients (93.22%). This was followed by daytime sleepiness in 47 patients (79.66%), waking up tired in 37 patients (62.71%), and disturbed sleep in 36 patients (61.02%).
Conclusion: The prevalence of OSA is notably high among individuals with MS. Consequently, routine assessment for OSA should be an integral component of the management strategy for patients with MS.
Downloads
References
Swarup S, Ahmed I, Grigorova Y, Zeltser R. Metabolic syndrome. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024 Mar 7.
Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: Exercise as medicine? BMC Sports Sci Med Rehabil. 2018 May 4;10:7. doi: 10.1186/s13102-018-0097-1, PMID: 29755739
Hill JJ. Obesity: An emerging threat. J Natl Black Nurses Assoc. 2018;29(2):36-9. PMID: 31022338
Kim DH, Kim B, Han K, Kim SW. The relationship between metabolic syndrome and obstructive sleep apnea syndrome: A nationwide population-based study. Sci Rep. 2021 Apr 22;11(1):8751. doi: 10.1038/ s41598-021-88233-4, PMID: 33888816
Framnes SN, Arble DM. The bidirectional relationship between obstructive sleep apnea and metabolic disease. Front Endocrinol (Lausanne). 2018 Aug 6;9:440. doi: 10.3389/fendo.2018.00440, PMID: 30127766
Calvin AD, Albuquerque FN, Lopez-Jimenez F, Somers VK. Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord. 2009;7(4):271-8. doi: 10.1089/met.2008.0093, PMID: 19344228
Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci. 2023 Apr 26;24(9):7898. doi: 10.3390/ijms24097898, PMID: 37175603
Grundy SM. A constellation of complications: The metabolic syndrome. Clin Cornerstone. 2005;7:36-45. doi: 10.1016/s1098-3597(05)80066-3, PMID: 16473259
Lipsy RJ. The national cholesterol education program adult treatment panel III guidelines. J Manag Care Pharm. 2003;9(1 Suppl):2-5. doi: 10.18553/jmcp.2003.9.s1.2, PMID: 14613351
Goyal M, Johnson J. Obstructive sleep apnea diagnosis and management. Mo Med. 2017;114(2):120-4. PMID: 30228558
Gabbay IE, Lavie P. Age- and gender-related characteristics of obstructive sleep apnea. Sleep Breath. 2012;16(2):453-60. doi: 10.1007/ s11325-011-0523-z, PMID: 21499842
Geer JH, Hilbert J. Gender issues in obstructive sleep apnea. Yale J Biol Med. 2021 Sep 30;94(3):487-96. PMID: 34602886
Lin CM, Davidson TM, Ancoli-Israel S. Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev. 2008;12(6):481-96. doi: 10.1016/j.smrv.2007.11.003, PMID: 18951050
Dubey AP, Rajput AK, Suhag V, Sharma D, Kandpal A, Keisham R. Prevalence of obstructive sleep apnoea in metabolic syndrome. Int J Adv Med. 2017;4(3):722-7. doi: 10.18203/2349-3933.ijam20172261
Giampá SQ, Lorenzi-Filho G, Drager LF. Obstructive sleep apnea and metabolic syndrome. Obesity (Silver Spring). 2023;31(4):900-11. doi: 10.1002/oby.23679, PMID: 36863747
Gaines J, Vgontzas AN, Fernandez-Mendoza J, Bixler EO. Obstructive sleep apnea and the metabolic syndrome: The roadto clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev. 2018;42:211-9. doi: 10.1016/j. smrv.2018.08.009, PMID: 30279095
Khazaie H, Najafi F, Rezaie L, Tahmasian M, Sepehry AA, Herth FJ. Prevalence of symptoms and risk of obstructive sleep apnea syndrome in the general population. Arch Iran Med. 2011;14(5):335-8. doi: 10.1016/j.sleep.2013.11.390, PMID: 21888458
Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: A review. JAMA. 2020;323(14):1389-400. doi: 10.1001/ jama.2020.3514, PMID: 32286648
Sharma SK, Malik V, Vasudev C, Banga A, Mohan A, Handa KK, et al. Prediction of obstructive sleep apnea in patients presenting to a tertiary care center. Sleep Breath. 2006;10(3):147-54. doi: 10.1007/s11325- 006-0062-1, PMID: 16699807
Goyal A, Meena R, Gupta S, Kar A, Ali R, Bohra A, et al. Sex-specific differences in presenting symptoms of obstructive sleep apnea. Lung India. 2024;41(2):115-20. doi: 10.4103/lungindia.lungindia_235_22, PMID: 38700405
Published
How to Cite
Issue
Section
Copyright (c) 2024 BHAVYA SHIVALINGAIAH, MALLIKARJUN, VARSHINI J, SPURTHI K
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
